Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients

AIDS

Volumn 15, Issue 18, 2001, Pages 2385-2395

  Phillips, A N ^a   Pradier, C ^a   Lazzarin, A ^a   Clotet, B ^a   Goebel, F D ^a   Hermans, P ^a   Antunes, F ^a   Ledergerber, B ^a   Kirk, O ^a   Lundgren, J D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL TRIAL; EUROPE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0035824773     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200112070-00006     Document Type: Article

References (25)

1. Perspectives of non-nucleoside reverse transcriptase inhibitors in the therapy of HIV-1 infection
2. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
3. The atlantic study: A randomized open-label study comparing two protease inhibitor-sparing antiretroviral strategies versus a standard Pl-containing regimen
4. Preliminary results of a randomized multicenter study comparing zdv/3TC plus nelfinavir or nevirapine in HIV-infected naïve patients (COMBINE) study
5. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy
6. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
7. Changing patterns of mortality across Europe in patients infected with HIV-1
8. The changing spectrum of AIDS across Europe 1994-1998. Results from the EuroSIDA study
9. Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients
10. Randomized trials or observational tribulations?
11. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: Comparison of cohort studies with randomized trials
12. Treatment comparisons in HIV infection: The benefits and limitations of observational cohort studies
13. Virological response to protease inhibitor therapy in an HIV clinic cohort
14. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV cohort study
15. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: Results from the EuroSIDA study
16. Outcome and predictors of failure of highly active antiretroviral therapy: One-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons
17. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients
18. Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients
19. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection
20. Saquinavir hard gel suppresses viral load insufficiently in HIV- infected patients naive to anti-retroviral therapy: A retrospective cohort study
21. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor
22. The SENC trial: Spanish efavirenz vs nevirapine comparison trial. Preliminary results of a prospective, randomized, controlled, open-label study in HIV+ naive individuals
23. Impact of switching from protease inhibitors to nevirapine or efavirenz in patients with viral suppression
24. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy